Guest guest Posted July 15, 2010 Report Posted July 15, 2010 It’s one thing to discuss what a center may or may not include in a case rate (Mobilization? Donor services?). However, actual case rate ranges are not only proprietary but sharing them could also be seen as collusion & /or price fixing. That’s our center’s opinion, anyway. I suggest you look at a number of your transplant cases to see what your own center’s costs are, and then negotiate case rate payments that will give you an appropriate profit level and protection from catastrophic cases. Goldstein BMT Financial Specialist Stanford Blood & Marrow Transplant Program Confidentiality Notice This email communication and any attachments may contain confidential information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this email in error, please notify the sender immediately. From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of sduff37 Sent: Thursday, July 15, 2010 9:54 AM To: TxFinancialCoordinators Subject: BMT market analysis Our center wants to do a global case rate (professional & facility)analysis for autologous and allogeneic BMTs. Would any of your centers be willing to share low & high ranges, or averages of your global case rate contracts for these BMTs? Does anyone know where else I could gather this sort of information? Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.